Share on StockTwits

Analysts’ price target changes for Thursday, July 17th:

Abbott Laboratories (NYSE:ABT) had its price target increased by Stifel Nicolaus from $42.00 to $47.00. The firm currently has a buy rating on the stock.

ADTRAN (NASDAQ:ADTN) had its target price trimmed by Needham & Company LLC from $30.00 to $28.00. Needham & Company LLC currently has a buy rating on the stock.

AAR Corp. (NYSE:AIR) had its price target boosted by DA Davidson from $34.00 to $36.00. The firm currently has a buy rating on the stock.

BlackRock (NYSE:BLK) had its target price increased by RBC Capital from $387.00 to $397.00. RBC Capital currently has an outperform rating on the stock.

Citizens Financial (NASDAQ:CNFL) had its target price boosted by FBR Capital Markets from $18.00 to $20.00. They currently have a market perform rating on the stock.

CSX (NYSE:CSX) had its target price raised by Argus from $33.00 to $38.00. Argus currently has a buy rating on the stock.

Ensign Group (NASDAQ:ENSG) had its price target lowered by Oppenheimer from $51.00 to $38.00. Oppenheimer currently has an outperform rating on the stock.

HCA Holdings (NYSE:HCA) had its target price increased by Jefferies Group to $72.00.

iGATE (NASDAQ:IGTE) had its price target increased by Needham & Company LLC from $48.00 to $50.00. The firm currently has a buy rating on the stock.

Las Vegas Sands Corp. (NYSE:LVS) had its price target cut by Stifel Nicolaus from $100.00 to $95.00. They currently have a buy rating on the stock.

Pinnacle Financial Partners (NASDAQ:PNFP) had its target price boosted by Wunderlich from $37.00 to $40.00. They currently have a hold rating on the stock. The analysts wrote, “We maintain our Hold rating on shares of Pinnacle Financial Partners (PNFP) although we are raising our price target from $37 to $40 at this time. PNFP reported 2Q14 EPS of $0.49, which was $0.01 ahead of consensus and $0.02 better than our EPS estimate. Although the quality of PNFP’s beat in 2Q14 was low as it was fueled by a reduced provision, the company’s pace of originations accelerated nicely and management raised its long-term ROAA targets, which is a proxy for increased guidance, in our view. PNFP is perhaps the best example of an above-average organic growth story among the Southeastern banks; however, we believe that the company’s fundamental strength is largely reflected in PNFP’s current share price, hence our Hold rating at this time.”

St. Jude Medical (NYSE:STJ) had its target price raised by Canaccord Genuity from $47.00 to $51.00. They currently have a sell rating on the stock.

Time Warner (NYSE:TWX) had its price target raised by RBC Capital from $73.00 to $76.00. RBC Capital currently has an outperform rating on the stock.

Time Warner (NYSE:TWX) had its price target boosted by Topeka Capital Markets from $68.00 to $70.00. They currently have a hold rating on the stock.

Time Warner (NYSE:TWX) had its target price raised by FBR Capital Markets from $80.00 to $90.00. They currently have an outperform rating on the stock.

Textron (NYSE:TXT) had its target price boosted by RBC Capital from $42.00 to $44.00. They currently have an outperform rating on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.